Association between screening and the thyroid cancer "epidemic" in South Korea: Evidence from a nationwide study

BMJ (Online)

Volumn 355, Issue , 2016, Pages

  Park, Sohee ^a,b   Oh, Chang Mo ^a   Cho, Hyunsoon ^a   Lee, Joo Young ^a,c   Jung, Kyu Won ^a   Jun, Jae Kwan ^a   Won, Young Joo ^a   Kong, Hyun Joo ^a   Choi, Kui Son ^a   Lee, You Jin ^a   Lee, Jin Soo ^a  

^a National Cancer Center   (South Korea)

^b Yonsei University   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER REGISTRY; CANCER SCREENING; CANCER STAGING; DISEASE ASSOCIATION; EPIDEMIC; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REGIONAL SURVEILLANCE EPIDEMIOLOGY AND END RESULTS SUMMARY STAGE; SOUTH KOREA; STANDARDIZED INCIDENCE RATIO; THYROID CANCER; THYROID PAPILLARY CARCINOMA; TUMOR LOCALIZATION; TUMOR VOLUME; CARCINOMA; HEALTH SURVEY; INCIDENCE; MASS SCREENING; PATHOLOGY; REGISTER; RETROSPECTIVE STUDY; THYROID NEOPLASMS;

CARCINOMA; FEMALE; HEALTH SURVEYS; HUMANS; INCIDENCE; LYMPHATIC METASTASIS; MALE; MASS SCREENING; MIDDLE AGED; REGISTRIES; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; THYROID NEOPLASMS;

EID: 85002244028     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.i5745     Document Type: Article

References (42)

1. La Vecchia C, Malvezzi M, Bosetti C, et al. Thyroid cancer mortality and incidence: a global overview. Int J Cancer 2015;136:2187-95. doi:10.1002/ijc.29251.
2. Jung KW, Park S, Kong HJ, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2009. Cancer Res Treat 2012;44:11-24. doi:10.4143/crt.2012.44.1.11.
3. Won YJ, Sung J, Jung KW, et al. Nationwide cancer incidence in Korea, 2003-2005. Cancer Res Treat 2009;41:122-31. doi:10.4143/crt.2009.41.3.122.
4. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC CancerBase No. 11. International Agency for Research on Cancer, 2013, http://globocan.iarc.fr.
5. Lee KS, Chang HS, Lee SM, Park EC. Economic burden of cancer in Korea during 2000-2010. Cancer Res Treat 2015;47:387-98. doi:10.4143/crt.2014.001.
6. Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 2014;74:2913-21. doi:10.1158/0008-5472.CAN-14-0155.
7. Lubitz CC, Kong CY, McMahon PM, et al. Annual financial impact of well-differentiated thyroid cancer care in the United States. Cancer 2014;120:1345-52. doi:10.1002/cncr.28562.
8. Ahn HS, Kim HJ, Welch HG. Korea's thyroid-cancer "epidemic"-screening and overdiagnosis. N Engl J Med 2014;371:1765-7. doi:10.1056/NEJMp1409841.
9. Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst 2010;102:605-13. doi:10.1093/jnci/djq099.
10. Jung KW, Won YJ, Kong HJ, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012. Cancer Res Treat 2015;47:127-41. doi:10.4143/crt.2015.060.
11. Oh CM, Jung KW, Won YJ, Shin A, Kong HJ, Lee JS. Age-period-cohort analysis of thyroid cancer incidence in Korea. Cancer Res Treat 2015;47:362-9. doi:10.4143/crt.2014.110.
12. Morris LG, Myssiorek D. Improved detection does not fully explain the rising incidence of well-differentiated thyroid cancer: a population-based analysis. Am J Surg 2010;200:454-61. doi:10.1016/j.amjsurg.2009.11.008.
13. Pandeya N, McLeod DS, Balasubramaniam K, et al. Increasing thyroid cancer incidence in Queensland, Australia 1982-2008-true increase or overdiagnosis? Clin Endocrinol (Oxf) 2015. doi:10.1111/cen.12724.
14. Yoo F, Chaikhoutdinov I, Mitzner R, Liao J, Goldenberg D. Characteristics of incidentally discovered thyroid cancer. JAMA Otolaryngol Head Neck Surg 2013;139:1181-6. doi:10.1001/jamaoto.2013.5050.
15. Oh CM, Park S, Lee JY, et al. Increased prevalence of chronic lymphocytic thyroiditis in Korean patients with papillary thyroid cancer. PLoS One 2014;9:e99054. doi:10.1371/journal.pone.0099054.
16. Greene FL, Page DL, Fleming ID, et al, eds. AJCC cancer staging manual. 6th ed. Springer-Verlag Press, 2002 doi:10.1007/978-1-4757-3656-4.
17. Young JL Jr, Roffers SD, Ries LAG, et al. SEER summary staging manual 2000: Codes and coding instructions. NIH Pub. No. 01-4969. National Cancer Institute, 2001.
18. Hay ID, Johnson TR, Thompson GB, Sebo TJ, Reinalda MS. Minimal extrathyroid extension in papillary thyroid carcinoma does not result in increased rates of either cause-specific mortality or postoperative tumor recurrence. Surgery 2016;159:11-21. doi:10.1016/j.surg.2015.05.046.
19. Fritz A, Percy C, Jack A, et al, eds. International Classification of Diseases for Oncology. 3rd ed. World Health Organization, 2000.
20. Forman D, Bray F, Brewster DH, et al, eds. (electronic version). Vol XIARC, 2013. (Cancer incidence in five continents.).
21. Segi M. Cancer mortality for selected sites in 24 countries (1950-57). Department of Public Health, Tohoku University of Medicine, 1960.
22. Kim SH, Jung SL, Moon WJ, et al. The prevalence of thyroid nodules and thyroid cancers in the Koreans: The nationwide data analysis of thyroid ultrasonography in 2004. J Korean Thyroid Assoc 2009;2:33-7.
23. Jung KW, Won YJ, Kong HJ, Oh CM, Shin A, Lee JS. Survival of Korean adult cancer patients by stage at diagnosis, 2006-2010: national cancer registry study. Cancer Res Treat 2013;45:162-71. doi:10.4143/crt.2013.45.3.162.
24. Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 2016;26:1-133. doi:10.1089/thy.2015.0020.
25. Ahn HS, Welch HG. South Korea's thyroid-cancer "epidemic"-turning the tide. N Engl J Med 2015;373:2389-90. doi:10.1056/NEJMc1507622.
26. Davies L, Welch HG. Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg 2014;140:317-22. doi:10.1001/jamaoto.2014.1.
27. Han MA, Choi KS, Lee HY, Kim Y, Jun JK, Park EC. Current status of thyroid cancer screening in Korea: results from a nationwide interview survey. Asian Pac J Cancer Prev 2011;12:1657-63.
28. Davies L, Morris LG, Haymart M, et al. AACE Endocrine Surgery Scientific Committee. American Association of Clinical Endocrinologists and American College of Endocrinology disease state clinical review: the increasing incidence of thyroid cancer. Endocr Pract 2015;21:686-96. doi:10.4158/EP14466.DSCR.
29. Pellegriti G, Frasca F, Regalbuto C, Squatrito S, Vigneri R. Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol 2013;2013:965212. doi:10.1155/2013/965212.
30. Brito JP, Morris JC, Montori VM. Thyroid cancer: zealous imaging has increased detection and treatment of low risk tumours. BMJ 2013;347:f4706. doi:10.1136/bmj.f4706.
31. Chen AY, Jemal A, Ward EM. Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer 2009;115:3801-7. doi:10.1002/cncr.24416.
32. Bahl M, Sosa JA, Nelson RC, Esclamado RM, Choudhury KR, Hoang JK. Trends in incidentally identified thyroid cancers over a decade: a retrospective analysis of 2,090 surgical patients. World J Surg 2014;38:1312-7. doi:10.1007/s00268-013-2407-9.
33. Malone MK, Zagzag J, Ogilvie JB, Patel KN, Heller KS. Thyroid cancers detected by imaging are not necessarily small or early stage. Thyroid 2014;24:314-8. doi:10.1089/thy.2012.0651.
34. Veiga LH, Holmberg E, Anderson H, et al. Thyroid cancer after childhood exposure to external radiation: an updated pooled analysis of 12 studies. Radiat Res 2016;185:473-84. doi:10.1667/RR14213.1.
35. Kweon SS, Shin MH, Chung IJ, Kim YJ, Choi JS. Thyroid cancer is the most common cancer in women, based on the data from population-based cancer registries, South Korea. Jpn J Clin Oncol 2013;43:1039-46. doi:10.1093/jjco/hyt102.
36. Grodski S, Brown T, Sidhu S, et al. Increasing incidence of thyroid cancer is due to increased pathologic detection. Surgery 2008;144:1038-43, discussion 1043. doi:10.1016/j.surg.2008.08.023.
37. Ito Y, Uruno T, Nakano K, et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid 2003;13:381-7. doi:10.1089/105072503321669875.
38. Castro MR, Morris JC, Ryder M, Brito JP, Hay ID. Most patients with a small papillary thyroid carcinoma enjoy an excellent prognosis and may be managed with minimally invasive therapy or active surveillance. Cancer 2015;121:3364-5. doi:10.1002/cncr.29468.
39. Miyauchi A. Clinical trials of active surveillance of papillary microcarcinoma of the thyroid. World J Surg 2016;40:516-22. doi:10.1007/s00268-015-3392-y.
40. Oda H, Miyauchi A, Ito Y, et al. Incidences of unfavorable events in the management of low-risk papillary microcarcinoma of the thyroid by active surveillance versus immediate surgery. Thyroid 2016;26:150-5. doi:10.1089/thy.2015.0313.
41. Yi KH, Park YJ, Koong SS, et al. Revised Korean thyroid association management guidelines for patients with thyroid nodules and thyroid cancer. Endocrinol Metab (Seoul) 2010;25:270-97 doi:10.3803/EnM.2010.25.4.270.
42. Yi KH, Kim SY, Kim DH, et al. The Korean guideline for thyroid cancer screening. J Korean Med Assoc 2015;58:302-12 doi:10.5124/jkma.2015.58.4.302.